240 related articles for article (PubMed ID: 9240087)
1. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D
Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087
[TBL] [Abstract][Full Text] [Related]
2. A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent.
Xiao Y; Xue R; You T; Li X; Pei F
Magn Reson Imaging; 2015 Jul; 33(6):822-8. PubMed ID: 25839395
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
4. First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity.
Livramento JB; Weidensteiner C; Prata MI; Allegrini PR; Geraldes CF; Helm L; Kneuer R; Merbach AE; Santos AC; Schmidt P; Tóth E
Contrast Media Mol Imaging; 2006; 1(1):30-9. PubMed ID: 17193598
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
Tweedle MF; Wedeking P; Kumar K
Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
[TBL] [Abstract][Full Text] [Related]
6. Gd-DOTA: characterization of a new paramagnetic complex.
Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics.
Lim J; Turkbey B; Bernardo M; Bryant LH; Garzoni M; Pavan GM; Nakajima T; Choyke PL; Simanek EE; Kobayashi H
Bioconjug Chem; 2012 Nov; 23(11):2291-9. PubMed ID: 23035964
[TBL] [Abstract][Full Text] [Related]
8. Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics.
Shiraishi K; Kawano K; Maitani Y; Yokoyama M
J Control Release; 2010 Dec; 148(2):160-7. PubMed ID: 20804796
[TBL] [Abstract][Full Text] [Related]
9. Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging.
Lu ZR; Wang X; Parker DL; Goodrich KC; Buswell HR
Bioconjug Chem; 2003; 14(4):715-9. PubMed ID: 12862423
[TBL] [Abstract][Full Text] [Related]
10. Polymeric conjugates of Gd(3+)-diethylenetriaminepentaacetic acid and dextran. 2. Influence of spacer arm length and conjugate molecular mass on the paramagnetic properties and some biological parameters.
Rebizak R; Schaefer M; Dellacherie E
Bioconjug Chem; 1998; 9(1):94-9. PubMed ID: 9460551
[TBL] [Abstract][Full Text] [Related]
11. Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits.
Loubeyre P; Canet E; Zhao S; Benderbous S; Amiel M; Revel D
Invest Radiol; 1996 May; 31(5):288-93. PubMed ID: 8724128
[TBL] [Abstract][Full Text] [Related]
12. P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results.
Port M; Corot C; Rousseaux O; Raynal I; Devoldere L; Idée JM; Dencausse A; Le Greneur S; Simonot C; Meyer D
MAGMA; 2001 May; 12(2-3):121-7. PubMed ID: 11390267
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents.
Tweedle MF
Invest Radiol; 1992 Aug; 27 Suppl 1():S2-6. PubMed ID: 1506149
[No Abstract] [Full Text] [Related]
14. Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging.
Anelli PL; Lattuada L; Lorusso V; Lux G; Morisetti A; Morosini P; Serleti M; Uggeri F
J Med Chem; 2004 Jul; 47(14):3629-41. PubMed ID: 15214790
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
[TBL] [Abstract][Full Text] [Related]
16. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.
Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE
Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of HE-24.8: a polymeric contrast agent for magnetic resonance angiography.
Kiessling F; Heilmann M; Lammers T; Ulbrich K; Subr V; Peschke P; Waengler B; Mier W; Schrenk HH; Bock M; Schad L; Semmler W
Bioconjug Chem; 2006; 17(1):42-51. PubMed ID: 16417250
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo comparative performance studies of gadolinium-loaded zeolites and Gd-DOTA as contrast agents for MRI applications.
Contro J; Silva DA; Santisteban OAN; Narayana PA; Nery JG
J Biomed Mater Res B Appl Biomater; 2021 Aug; 109(8):1105-1115. PubMed ID: 33283412
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging.
Ke T; Feng Y; Guo J; Parker DL; Lu ZR
Magn Reson Imaging; 2006 Sep; 24(7):931-40. PubMed ID: 16916710
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.
Fretellier N; Bouzian N; Parmentier N; Bruneval P; Jestin G; Factor C; Mandet C; Daubiné F; Massicot F; Laprévote O; Hollenbeck C; Port M; Idée JM; Corot C
Toxicol Sci; 2013 Jan; 131(1):259-70. PubMed ID: 22977165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
